| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1900* | 2021 |
| Exercise in obesity—the role of technology in health services: can this approach work? LJ Dobbie, A Tahrani, U Alam, J James, J Wilding, DJ Cuthbertson Current obesity reports, 1-14, 2021 | 21 | 2021 |
| Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open … O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 401 (10387), 1499-1507, 2023 | 15 | 2023 |
| The impact of the COVID-19 pandemic on mobility trends and the associated rise in population-level physical inactivity: Insights From International Mobile Phone and National … LJ Dobbie, TJ Hydes, U Alam, A Tahrani, DJ Cuthbertson Frontiers in sports and active living 4, 773742, 2022 | 15 | 2022 |
| Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis LJ Dobbie, B Pittam, SS Zhao, U Alam, TJ Hydes, TM Barber, ... Human Reproduction 38 (6), 1168-1182, 2023 | 14 | 2023 |
| Validation of semi-automated flow-mediated dilation measurement in healthy volunteers LJ Dobbie, ST Mackin, K Hogarth, F Lonergan, D Kannenkeril, ... Blood Pressure Monitoring 25 (4), 216-223, 2020 | 14 | 2020 |
| Low screening rates despite a high prevalence of significant liver fibrosis in people with diabetes from primary and secondary care LJ Dobbie, M Kassab, AS Davison, P Grace, DJ Cuthbertson, TJ Hydes Journal of Clinical Medicine 10 (24), 5755, 2021 | 10 | 2021 |
| Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet Diabetes & Endocrinology 11 (12), 905-914, 2023 | 8 | 2023 |
| Thromboprophylaxis in congenital nephrotic syndrome: 15-year experience from a national cohort LJ Dobbie, A Lamb, L Eskell, IJ Ramage, BC Reynolds Pediatric Nephrology 36, 1183-1194, 2021 | 5 | 2021 |
| Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised … SN Faust, R Haynes, CE Jones, N Staplin, E Whittaker, T Jaki, E Juszczak, ... The Lancet Child & Adolescent Health 8 (3), 190-200, 2024 | 4 | 2024 |
| Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial C Coelho, LJ Dobbie, J Crane, A Douiri, AE Learoyd, O Okolo, ... International Journal of Obesity 47 (11), 1132-1142, 2023 | 4 | 2023 |
| Clinical evaluation of patients living with obesity LJ Dobbie, C Coelho, J Crane, B McGowan Internal and Emergency Medicine 18 (5), 1273-1285, 2023 | 3 | 2023 |
| Role of Exercise and Physical Activity in Promoting Weight Loss and Weight Loss Maintenance DJ Cuthbertson, LJ Dobbie Clinical Obesity in Adults and Children, 262-278, 2022 | 3 | 2022 |
| Effect of a Low-Calorie Dietary Intervention on Liver Health and Body Weight in Adults with Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Overweight … LJ Dobbie, J Burgess, A Hamid, SJ Nevitt, TJ Hydes, U Alam, ... Nutrients 16 (7), 1030, 2024 | | 2024 |
| Liraglutide 3.0 mg in the treatment of adults with obesity and prediabetes using real‐world UK data: A clinical evaluation of a multi‐ethnic population LJ Dobbie, C Coelho, F Mgaieth, K Chauhan, S Campbell, S Shuriye, ... Clinical Obesity, e12649, 2024 | | 2024 |
| Real‐world data of a digitally enabled, time‐restricted eating weight management program in public sector workers living with overweight and obesity in the United Kingdom: A … A Brown, LJ Dobbie, L Falvey, DC Patel, JTC Kwan, S Steinmo, L Chow, ... Obesity Science & Practice 10 (1), e730, 2024 | | 2024 |
| Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial P Sandercock, J Darbyshire, D DeMets, R Fowler, D Lalloo, M Munavvar, ... Nature Communications 15, 2024 | | 2024 |
| Mendelian randomisation reveals Sodium-glucose Cotransporter-1 inhibition's potential in reducing Non-Alcoholic Fatty Liver Disease risk LJ Dobbie, DJ Cuthbertson, TJ Hydes, U Alam, SS Zhao European Journal of Endocrinology 188 (6), K33-K37, 2023 | | 2023 |
| Efficacy of the Low-Calorie Diet in the Treatment of Adults Living with NAFLD and Obesity: A Systematic Review and Meta-analysis DJC L J Dobbie, J Burgess, A Hamid, S Nevitt, T Hydes, U Alam Obesity Facts 16 (S1), 1-351, 2023 | | 2023 |
| Clinical Evaluation of Liraglutide 3.0mg In the Treatment of Obesity using Real-World UK Data BMG L.J Dobbie, C Coelho, K Chauhan, S Campbell, J Hollington, D Alves, S ... Obesity Facts, 2023 | | 2023 |
